Laurie Ferret
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laurie Ferret has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Amélie Boursier
Pharmacie clinique, Pôle 8 Cancérologie et spécialités médicales, Centre hospitalier de Valenciennes, 114, avenue Desandrouin, 59300 Valenciennes, France
2 shared publications - Antoine Lemaire
Department of Oncology, Centre Hospitalier de Valenciennes, 59300 Valenciennes, France
2 shared publications - Arnaud Potier
Service de pharmacie, CH de Luneville, 54300 Luneville, France; Service de pharmacie, CHRU de Nancy, 54000 Nancy, France
2 shared publications - Edouard Poncelet
Service d’imagerie de la femme, centre hospitalier de Valenciennes, 59300 Valenciennes, France
2 shared publications - Julie Fulcrand
Centre Hospitalier de Valenciennes, pôle 8 cancérologie et spécialités médicales, avenue Desandrouin, 59300 Valenciennes, France
2 shared publications - Julie Heiremans
Centre Hospitalier de Valenciennes, pôle 8 cancérologie et spécialités médicales, avenue Desandrouin, 59300 Valenciennes, France
2 shared publications
Latest Publications
- 26 December 2025
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 61 (3) , 275-282
Favoriser l’utilisation et l’évaluation d’un système d’aide à la décision pharmaceutique : création d’un glossaire francophone des principaux termes utilisés
- 26 December 2025
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 61 (3) , 275-282
Favoriser l’utilisation et l’évaluation d’un système d’aide à la décision pharmaceutique : création d’un glossaire francophone des principaux termes utilisés
- Open Access
- 24 January 2024
- Published by MDPI AG in Preprints.org
Comparative Clinical Evaluation of 3 Artificial Intelligence Algorithms for Breast Cancer Screening with Mammography
Objectives: Few studies have evaluated and compared artificial intelligence (AI) models for breast cancer detection on the same database. The purpose is to compare the performances of 3 artificial intelligence algorithms on the same dataset at a free operative threshold and to evaluate how the performance is impacted by the chosen threshold. Materials: In this retrospective single-center study, a dataset of 314 2D screening mammograms performed between 2012 and 2020 was established with a prevalence of 19.6% of histologically proven cancer. Three AI constructors using CE (European conformity) marking algorithms have agreed to take part in the study by submitting the cancer-enriched cohort to their algorithm. They chose a free operative threshold to distinguish benign and malignant mammograms. The most suspicious lesion was marked and correctly located by the AI algorithm. Statistical parameters were analyzed and compared between the algorithms. Results: Regarding both sensitivity and specificity, at the chosen threshold, AI 1 had the best compromise between sensitivity (74%) and specificity (79%). AI 2 had a statistically lower sensitivity (52%; p<0.05) with a higher specificity (98.4%) than the other AI algorithms. AI 3 had a nonsignificant sensitivity difference (69.9%) but a significantly lower specificity (45.3%; p<0.001) than the other two. The performances varied depending on the chosen threshold; when the AI 2 threshold was lowered, the sensitivity increased (69.9%), while a higher specificity (86.1%) was maintained. Conclusion: Two AI algorithms stood out in terms of performance when the threshold was optimized, resulting in an acceptable sensitivity and specificity.
- 24 January 2024
- Published by MDPI AG in Preprints.org
Open AccessComparative Clinical Evaluation of 3 Artificial Intelligence Algorithms for Breast Cancer Screening with Mammography
Objectives: Few studies have evaluated and compared artificial intelligence (AI) models for breast cancer detection on the same database. The purpose is to compare the performances of 3 artificial intelligence algorithms on the same dataset at a free operative threshold and to evaluate how the performance is impacted by the chosen threshold. Materials: In this retrospective single-center study, a dataset of 314 2D screening mammograms performed between 2012 and 2020 was established with a prevalence of 19.6% of histologically proven cancer. Three AI constructors using CE (European conformity) marking algorithms have agreed to take part in the study by submitting the cancer-enriched cohort to their algorithm. They chose a free operative threshold to distinguish benign and malignant mammograms. The most suspicious lesion was marked and correctly located by the AI algorithm. Statistical parameters were analyzed and compared between the algorithms. Results: Regarding both sensitivity and specificity, at the chosen threshold, AI 1 had the best compromise between sensitivity (74%) and specificity (79%). AI 2 had a statistically lower sensitivity (52%; p<0.05) with a higher specificity (98.4%) than the other AI algorithms. AI 3 had a nonsignificant sensitivity difference (69.9%) but a significantly lower specificity (45.3%; p<0.001) than the other two. The performances varied depending on the chosen threshold; when the AI 2 threshold was lowered, the sensitivity increased (69.9%), while a higher specificity (86.1%) was maintained. Conclusion: Two AI algorithms stood out in terms of performance when the threshold was optimized, resulting in an acceptable sensitivity and specificity.
- Open Access
- 12 August 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (16) , 2662
Three-Dimensional Measurement of the Uterus on Magnetic Resonance Images: Development and Performance Analysis of an Automated Deep-Learning Tool
Uterus measurements are useful for assessing both the treatment and follow-ups of gynaecological patients. The aim of our study was to develop a deep learning (DL) tool for fully automated measurement of the three-dimensional size of the uterus on magnetic resonance imaging (MRI). In this single-centre retrospective study, 900 cases were included to train, validate, and test a VGG-16/VGG-11 convolutional neural network (CNN). The ground truth was manual measurement. The performance of the model was evaluated using the objective key point similarity (OKS), the mean difference in millimetres, and coefficient of determination R2. The OKS of our model was 0.92 (validation) and 0.96 (test). The average deviation and R2 coefficient between the AI measurements and the manual ones were, respectively, 3.9 mm and 0.93 for two-point length, 3.7 mm and 0.94 for three-point length, 2.6 mm and 0.93 for width, 4.2 mm and 0.75 for thickness. The inter-radiologist variability was 1.4 mm. A three-dimensional automated measurement was obtained in 1.6 s. In conclusion, our model was able to locate the uterus on MRIs and place measurement points on it to obtain its three-dimensional measurement with a very good correlation compared to manual measurements.
- 12 August 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (16) , 2662
Open AccessThree-Dimensional Measurement of the Uterus on Magnetic Resonance Images: Development and Performance Analysis of an Automated Deep-Learning Tool
Uterus measurements are useful for assessing both the treatment and follow-ups of gynaecological patients. The aim of our study was to develop a deep learning (DL) tool for fully automated measurement of the three-dimensional size of the uterus on magnetic resonance imaging (MRI). In this single-centre retrospective study, 900 cases were included to train, validate, and test a VGG-16/VGG-11 convolutional neural network (CNN). The ground truth was manual measurement. The performance of the model was evaluated using the objective key point similarity (OKS), the mean difference in millimetres, and coefficient of determination R2. The OKS of our model was 0.92 (validation) and 0.96 (test). The average deviation and R2 coefficient between the AI measurements and the manual ones were, respectively, 3.9 mm and 0.93 for two-point length, 3.7 mm and 0.94 for three-point length, 2.6 mm and 0.93 for width, 4.2 mm and 0.75 for thickness. The inter-radiologist variability was 1.4 mm. A three-dimensional automated measurement was obtained in 1.6 s. In conclusion, our model was able to locate the uterus on MRIs and place measurement points on it to obtain its three-dimensional measurement with a very good correlation compared to manual measurements.
- 1 March 2022
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 57 (1) , 28-34
Intégration de pharmaciens cliniciens au sein d’un Centre d’évaluation et de traitement de la douleur : retour d’expérience et perspectives
- 1 March 2022
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 57 (1) , 28-34
Intégration de pharmaciens cliniciens au sein d’un Centre d’évaluation et de traitement de la douleur : retour d’expérience et perspectives
- 1 March 2022
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 57 (1) , 16-21
Le pharmacien clinicien : un membre à part entière de l’équipe de soins, au service du patient COVID
- 1 March 2022
- Published by Elsevier in Le Pharmacien Clinicien
- Vol. 57 (1) , 16-21
Le pharmacien clinicien : un membre à part entière de l’équipe de soins, au service du patient COVID